Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2023
February
08
As Qiagen Q4 net sales declined 14%, base business sales grew double digits
Measuring NT-proBNP changes over time may improve risk stratification for heart patients
Cases
BD nabs FDA authorization for SARS-CoV-2, influenza A/B, RSV combination test
Bio-Rad, Element Biosciences collaborate on RNA library prep with benchtop sequencer
UnitedHealthcare increases coverage for Guardant360 CDx liquid biopsy test
Curio Bioscience emerges from stealth mode with whole-transcriptome spatial mapping kit
Page 1 of 1